There was absolute despair in the supplement community a few months ago.
A study on taurine appeared to smash the hopes that taurine supplements could extend lifespan.
The controversy never quite justified the reaction — and the evidence continued to support taurine supplementation. A new human meta-analysis of 1,394 people published on the 23rd of November 2025 reinforces that conclusion.
Here is a full breakdown of the controversy and what the data actually shows.
Table of Contents
- Taurine Overview and Early Studies
- The 2023 Animal Study
- The Controversial Follow-Up Study
- Why the Panic Wasn't Justified
- What the Human Data Really Shows
- The New Meta-Analysis of 1,394 People
- Taurine Dosage and Form
- References
Taurine Overview and Early Studies
Taurine is an amino acid. It's found naturally in the body, especially in the brain, heart, and muscles. It plays many roles, from energy metabolism to supporting nervous system function. Having too little can cause problems. It leads, for instance, to a condition called cardiomyopathy, which makes it hard for the heart to function properly [1].
It is becoming clear that taurine deficiency is also associated with cardiomyopathy in humans [1].
And for decades, taurine has been added to energy drinks.
But more recently, interest in taurine has surged in relation to aging. But why?
Awareness of taurine's possible health effects isn't new. For a long time, the focus was on heart health. For instance, a study back in 1984 found a significant positive impact of taurine supplements in heart failure patients [2].
But then, in the early 2000s, researchers noticed an intriguing link. They were looking at taurine intakes and heart disease mortality rates across 61 populations in 25 countries. One group jumped out—the Japanese. They had the lowest mortality rates. And they also get unusually high amounts of taurine in their diets [3].
But that's just observational data, which can easily be misleading. So while exciting, more robust evidence was needed to have a clearer picture of what's going on.
The 2023 Animal Study
A decisive tipping point came with the publication of a hugely important study in 2023. The authors found that taurine supplementation indeed seems to improve various markers associated with aging in mice and monkeys [4].
They discovered that taurine also extended average lifespan in mice and worms in the lab. The median lifespan of taurine-treated mice increased by 10 to 12%, and life expectancy at 28 months increased by about 18 to 25%. It also increased lifespan in multicellular worms [4].
Importantly, they also argued that taurine levels tend to drop with aging. They found this pattern to hold across mice, monkeys, and humans. Blood concentration of taurine declines with age in mice, monkeys, and humans [4].
The researchers connected the dots: taurine levels drop as we age, and supplementing with taurine counteracts some of the processes of aging and yields a healthier, longer life in animal models.
They were careful about what they said. They identified taurine deficiency as a driver of aging just in mice, worms, and monkeys. Taurine abundance decreases during aging. A reversal of this decline through taurine supplementation increases health span and lifespan in mice and worms, and health span in monkeys [4].
What about humans? The researchers stated clearly that more data was needed. To test whether taurine deficiency is a driver of aging in humans as well, long-term, well-controlled taurine supplementation trials that measure health span and lifespan as outcomes are required [4].
That didn't stop the supplement market for taurine from exploding. It was touted loudly online as an anti-aging supplement.
The Controversial Follow-Up Study
Then came a follow-up study that sparked significant debate. The researchers behind it identified a potential flaw in the 2023 study. Though that 2023 study made headlines for uncovering a decline in taurine with aging, other studies had found the opposite to be true. In fact, as the authors of the follow-up study combed through the literature, they found that results were all over the map. Some studies have found a decrease in taurine with age. Some found an increase. Some found no change [5].
So the researchers wanted to find out what was actually going on.
To get a definitive answer to this question, they took a different approach than the 2023 study. It had to do with how they collected the data on taurine levels in relationship to age. And this turns out to be vitally important.
There are two very different ways to do this. On the one hand, researchers could assemble a group of people of a range of ages and check the taurine content in their blood. The result is a set of data points consisting of an age and a number representing taurine levels, put in order from youngest to oldest to see the pattern. This is what the authors of the earlier study did — a cross-sectional analysis — and it appeared that levels declined with age.
But there is another way to do it. Researchers could assemble a group of people and check their taurine levels, then check their levels again in 10 years. They could then compare how levels changed for the same individual through time. This is called a longitudinal study. This method takes longer, but it's also generally more accurate — because there are lots of other factors that could potentially explain differences in levels in a cross-sectional analysis.
To illustrate: suppose researchers were looking at cross-sectional data on the link between age and anxiety. Much higher levels of anxiety are observed among the young than the old today. Based on that, one might conclude anxiety is associated with youth and declines with age. But looking at longitudinal data, it appears that people who are now old experienced a lot less anxiety when they were young than those who are now young do. So tracking individuals through time, there may be no decline in anxiety with age — perhaps it even goes up.
In this new study on taurine, researchers considered cross-sectional data, but were also careful to collect longitudinal data, looking at how taurine levels change through time in the same individuals. Looking at things that way, a very different picture emerged.
They looked at data sets for humans, primates, and mice. The pattern was consistent. Taurine levels did not decline with age. In fact, the opposite seems to happen [5].
What's more, the researchers found taurine levels don't seem to correlate consistently with markers of aging. They examined muscle strength and body weight — two standard things that tend to change in predictable ways with age. But there was no consistent link with taurine levels [5].
It seemed the central idea behind the 2023 study was undercut. There isn't a pattern of declining taurine with age. Therefore, it looks like low taurine isn't necessarily a driver of aging. And, in turn, this suggests supplementing with taurine isn't going to slow it.
Cue the meltdown in the supplement community… but there was always good reason not to be swayed by the panic.
Why the Panic Wasn't Justified
Studies with mice and other kinds of early trials make lots of headlines. But the results seen there often turn out to be misleading. Many times, when experiments are run again, results turn out differently. This actually has a label: The reproducibility crisis.
Here's how bad it can be. A team of researchers analyzed 53 important studies linked to potential cancer treatments. They could only reproduce the findings of 6 of them. That's just 11% [6].
Sound health decisions should not rest primarily on mice studies. The more important question is what the human data shows.
What the Human Data Really Shows
There is a significant amount of human data on taurine. One study considered a large human population in England. Researchers drew on data from the EPIC-Norfolk cohort study. The study had an initial population of 30,000 adults. It followed them for 30 years [7].
They found that higher levels of taurine in the blood were associated with a lower BMI and a lower incidence of type 2 diabetes. They were also associated with lower levels of inflammation [1].
Association alone doesn't establish causation, which is why randomized controlled trials (RCTs) are the more important evidence base.
A 2024 meta-analysis combined the RCT data together [8].
The analysis included 25 trials involving over 1,000 participants. It found that taurine decreased:
- Blood pressure (SBP −3.999 mmHg; DBP −1.509 mmHg)
- Fasting blood sugar (−5.882 mg/dL)
- Triglycerides (−18.315 mg/dL)
- LDL cholesterol
- HbA1c (−0.341%)
- Fasting insulin (−1.521 mU/L)
- HOMA index (−0.693)
Taurine had no effect on body weight. The doses used in the studies varied between 0.5g and 6g per day. The analysis showed taurine is safe and appears to have positive metabolic benefits [8].
There's also some early evidence suggesting it could have a significant impact on brain health as well.
For instance, researchers looked at the association between levels of taurine in the blood and the incidence of Alzheimer's disease and dementia. Based on participants in the Framingham study, they found higher levels of taurine were associated with a 26% lower risk of dementia [9].
One advantage of taurine as a supplement is how it pairs with magnesium. Magnesium must be bonded to something — common forms include magnesium oxide (not well absorbed) and magnesium citrate. Bonding magnesium to taurate creates magnesium taurate. Since taurine is an amino acid, it allows the magnesium taurate to ride on amino acid transporters for potentially better absorption.
The New Meta-Analysis of 1,394 People
Taken together, the existing evidence base for taurine shows:
- At doses between 1–3 grams, it appears to be safe
- It appears to have metabolic benefits
- It pairs well with magnesium
And this new meta-analysis reinforces that evidence base.
It's a meta-analysis that included 34 randomized controlled trials. The focus was on risk factors linked to chronic conditions like heart disease and diabetes. The analysis revealed a collection of beneficial effects:
- Fasting blood sugar: −5.90 mg/dL
- HbA1c: −0.21%
- Fasting insulin: Standard mean difference −0.55
- HOMA index: −0.57 [10]
Taurine also helped with blood lipids:
- Triglycerides: −14.42 mg/dL
- Total cholesterol: −12.41 mg/dL
- LDL cholesterol: −5.08 mg/dL [10]
Blood pressure:
- Systolic: −4.38 mmHg
- Diastolic: −2.54 mmHg [10]
Markers of inflammation and oxidative stress also decreased:
- C-reactive protein: −1.26 SMD
- TNF-alpha: −0.35 pg/mL
- Malondialdehyde: −1.16 SMD [10]
It's a striking collection of positive impacts across an array of factors central to health, especially as we age.
Taurine Dosage and Form
Across the RCTs reviewed, the doses used varied between 0.5g and 6g per day, with the bulk of the metabolic benefit evidence concentrated in the 1–3g range.
As noted above, magnesium taurate is a convenient form that delivers both magnesium and taurine simultaneously. Magnesium taurate is 8% elemental magnesium. For example, 1575mg of total magnesium taurate material — the amount needed to deliver 126mg elemental magnesium — provides approximately 1449mg of taurine in a single compound.
126 / 0.08 = 1575
1575 - 126 = 1449 taurine
MicroVitamin+ powder includes an additional 1g of taurine on top of the magnesium taurate already present in MicroVitamin, making it a relevant option for those looking for higher taurine intake.
From the MicroVitamin range
MicroVitamin uses magnesium taurate — a form that delivers both magnesium and taurine via amino acid transporters. MicroVitamin provides approximately 1449mg of taurine from this compound, while MicroVitamin+ includes an additional 1g of free taurine on top of that.
References
1. https://www.sciencedirect.com/science/article/pii/S1347861323000749
2. https://onlinelibrary.wiley.com/doi/10.1002/clc.4960080507
3. https://link.springer.com/chapter/10.1007/978-0-387-75681-3_2
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC10630957/
5. https://www.science.org/doi/10.1126/science.adl2116
7. https://www.epic-norfolk.org.uk/
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC11099170/
